ALK and Hypocalcemia: Administration of T-2 can cause hypocalcemia, likely due to a decrease in Ca absorption and inactivation of ALK in small intestine mucosa; in turn, a pathological syndrome, such as spongy bones or osteoporosis, could be observed [60].